Bivalirudin use in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Insights from the prospective, multi-centre EUROVISION registry.
U LimbrunoA PicchiS GalliK HuberJ LipieckiD BernsteinE DeliargyrisP AnthopoulosC NienaberM HamonPublished in: Acute cardiac care (2014)
Bivalirudin usage in the setting of primary PCI provided excellent results in terms of 30-day outcome even in a real-world population.
Keyphrases